Future of Mobile Applications’ Privacy through the lens of CPRA

By Jayson Jin on

Where would we be without the advancements made in the past ten years? Most people use technology as a means to simplify their life; from waking up to the gentle chiming from their Bedtime application (“app”)[1] on their iPhone, listening to the latest NPR news update, using the Waze app to figure out the shortcuts … Continue Reading

Smart City Transportation: Privacy and Equity Among Key Stakeholders

By David Shannon on

As society’s ability to harness technology continues to grow at an exponential rate, many have already foreseen the great potential for benefit or great harm that may be produced as a result. One major area that this dichotomy can be seen is with the continued development of smart cities. Smart cities are “urban areas that widely employ information and communication technologies (ICT), such as different types of sensors collect data in order to manage resources and improve the quality of life in the city.”[1] Several of these technologies include drones, phone trackers, cell-tower-mimicking technologies, facial recognition, and license plate readers that are available to the police as well as private individuals.[2] However, others have been quick to note that these technologies “are the future.”[3] Climate change, population movements, and the need to better process movement of individuals within the city make these technologies necessary for a city to reach its full potential.[4] This requires a balancing of the benefits these technologies may grant a city, with the significant risks of privacy and security violations taking place.

Merits and Drawbacks in Compulsory Licenses of COVID-19 Vaccines: Protecting Public Health or Rewarding Innovation?

By Eva Xu on

The coronavirus disease 2019 (COVID-19), the acute illness due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was announced as a global pandemic by the World Health Organization (WHO) in March 2020.[1] Since then, leading pharmaceutical and biotechnology companies have started to race to create coronavirus disease 2019 (COVID-19) vaccines through a variety of platforms and candidates; the academia, the governments, and private companies have been collaborating in unprecedented ways.[2]

One critical question arises concerning such private and public funded development of COVID-19 vaccines: could the U.S. government seek compulsory licenses for government- or private-owned technologies and if it could, should it do so?

Writing a Meaningful Privacy Notice

By Barbara Clayton on

Privacy notices are meant to provide a meaningful and clear understanding of a company’s privacy practices so that consumers can make informed choices on sharing their information. However, privacy notices are often loaded with legal jargon, overwhelming to read and found to be meaningless. This article proposes that by investing the time to craft a privacy notice that is clear, easy-to-understand and transparent about a company’s actual privacy practices, companies can build goodwill and trust with customers and help to reduce the risk of regulatory actions.

Mass Media Then and Now: A Historical Framework for Regulating Controversial Speech On the Internet

By Karen Kramer on

Much as the rise of the Gutenberg press transformed communication and ushered in vast societal changes, the rise of the Internet continues to transform communication and society today.  It is helpful to think of “the media” as having undergone several distinct phases, each bringing about profound changes in the transmission of ideas.  Each phase has … Continue Reading

Project Nightingale – The Case for Google

By Monica Tapavalu on

It is no secret that major tech companies are entering the healthcare space by collaborating with
healthcare providers to create new tools for patients, hospitals, and insurers. On November 11, 2019, the
Wall Street Journal first reported on the previously unknown Project Nightingale, a partnership between
tech giant Google and Ascension, the second largest healthcare provider in America.

Project Nightingale – The Case for Increased Privacy

By Elizabeth Magnan on

In an increasingly connected world, where technology companies are gathering private and
personal information on millions of Americans, it is important to protect the personal health information
of each individual. Technology companies like Google, Amazon, and Apple are progressively moving
into the healthcare industry through patient’s medical records.

Does the Cloud Act give us a glimpse at a template for GDPR-like adequacy decisions in the US?

By Justin Hartley on

The Clarifying Lawful Overseas Use of Data Act (“Cloud Act”) was passed in 2018 and sought to
more efficiently facilitate law enforcement access to data. This was in response to issues with preexisting
U.S. laws like the Electronic Communications Privacy Act (“ECPA”) and, more specifically, the
Stored Communications Act (“SCA”), that were showing their age when applied to global cloud

Artificial intelligence and the fog of innovation: a deep-dive on governance and the liability of autonomous systems

By Brandon W. Jackson on

Alan Turing, in his famous 1950 paper, “Computing Machinery and Intelligence,” wrote, “we can only see a short distance ahead, but we can see plenty there that needs to be done.” This sentiment, expressed nearly 70 years ago in the context of whether machines can think, reflects the current momentum of recent technological breakthroughs to endow machines with the ability to make intelligent decisions — the concept of Artificial Intelligence (AI). While the notion of AI is not novel, it has recently become a driving factor in industry because of compounded advancements in the availability of big data, machine learning approaches and algorithms, and powerful computing mechanisms.

Defective Computer-aided Design Software Liability In 3d Bio-printed Human Organ Equivalents

By Jamil Ammar on

Three-dimensional (3D) bioprinting offers the exciting prospect of printing 3D multicellular human organs by combining a host of specialisms, including software development, biotechnology and tort law. 3D bioprinting methods rely on highly specialized computer software that incorporates computer-aided design (CAD). Optimizing development of CAD software is paramount to the quality of the final bioprinted organ.

Page 1 of 2